The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cells.


BACKGROUND:Liver cancer is one of the most frequent cancers in the world. Targeted therapy of cancer with specific inhibitors is developing and has shown promising antitumor efficacy. CCI-779 (temsirolimus), a specific inhibitor of mTOR (mammalian target of rapamycin), can block the mTOR signaling pathway. Here, we systematically examined the expression of mTOR and its downstream targets in liver cancer cells and normal liver cells, then investigated inhibitory effects of CCI-779 on mTOR signaling pathway and its role in regulating liver cancer cell growth. METHODS:The expression of mTOR and its downstream targets in Bel-7402 liver cancer cells and HL-7702 normal liver cells were examined by western blot. The mTOR specific inhibitor (CCI-779) was used to treat Bel-7402 cells to identify its effects on Bel-7402 cell growth and activity of mTOR signaling pathway in vitro. Cell viability tests were performed after the treatment of CCI-779. Western blot was applied to assess the changes of mTOR pathway and flow cytometry was used to analyze cell cycle of Bel-7402 cells after the treatment of CCI-779. RESULTS:mTOR, p70S6K, S6, and 4EBP1 were overexpressed in Bel-7402 cells compared with HL-7702 cells. Bel-7402 cells were sensitive to CCI-779. The survival rate of the cells treated with CCI-779 over 0.312 μM was significantly different compared with that of control (P < 0.05). CCI-779 inhibited the phosphorylation of mTOR (Ser2448), p70S6K (Thr389), S6 (Ser240/244), and 4EBP1 (Thr37/46) in different grades and the expressions of p70S6K, S6, and 4EBP1. As a result, CCI-779 induced a dose-dependent decrease in cell proliferation, G1/S arrest and damage of cell shape. CONCLUSIONS:Taken together, these data showed that CCI-779 can inhibit mTOR signaling and proliferation in Bel-7402 liver cancer cells in vitro. It offers a therapeutic intervention through inhibition of mTOR as a potential strategy for liver cancer.


Cancer Cell Int


Li S,Liang Y,Wu M,Wang X,Fu H,Chen Y,Wang Z




Has Abstract


2013-03-28 00:00:00










  • Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate.

    abstract:BACKGROUND:Phenethyl isothiocyanate (PEITC), present naturally in cruciferous vegetables, is a chemopreventive agent. It blocks initiation and post-initiation progression of carcinogenesis. Mechanism study in human prostate cancer cells revealed that PEITC is a dual inhibitor of aberrant DNA hypermethylation and histon...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Xue C,Pasolli HA,Piscopo I,Gros DJ,Liu C,Chen Y,Chiao JW

    更新日期:2014-03-31 00:00:00

  • DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups.

    abstract:Background:Renal cell carcinoma (RCC) is the most common kidney cancer and includes several molecular and histological subtypes with different clinical characteristics. The combination of DNA methylation and gene expression data can improve the classification of tumor heterogeneity, by incorporating differences at the ...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Chen W,Zhuang J,Wang PP,Jiang J,Lin C,Zeng P,Liang Y,Zhang X,Dai Y,Diao H

    更新日期:2019-07-16 00:00:00

  • Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling.

    abstract:BACKGROUND:Prostate cancer is a leading cause of male cancer specific mortality. When cure by radical prostatectomy is not possible the next line of prostate cancer treatment is androgen deprivation. However prolonged androgen deprivation often results in relapse and androgen-independent prostate cancer that is inevita...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Shaw G,Prowse DM

    更新日期:2008-03-18 00:00:00

  • TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response.

    abstract:Background:Emergence of resistance to molecular targeted therapy constitutes a limitation to clinical benefits in cancer treatment. Cross-resistance commonly happens with chemotherapeutic agents but might not with targeted agents. Methods:In the current study, TP53 wild-type cell lines with druggable MAPK pathway muta...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Wu CE,Koay TS,Ho YH,Lovat P,Lunec J

    更新日期:2019-03-07 00:00:00

  • The mRNA expression of SATB1 and SATB2 in human breast cancer.

    abstract:BACKGROUND:SATB1 is a nuclear protein that has been recently reported to be a 'genome organizer' which delineates specific epigenetic modifications at target gene loci, directly up-regulating metastasis-associated genes while down-regulating tumor-suppressor genes. In this study, the level of mRNA expression of SATB1 a...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Patani N,Jiang W,Mansel R,Newbold R,Mokbel K

    更新日期:2009-07-30 00:00:00

  • Investigation of the apoptotic way induced by digallic acid in human lymphoblastoid TK6 cells.

    abstract:BACKGROUND:The digallic acid (DGA) purified from Pistacia lentiscus. L fruits was investigated for its antiproliferative and apoptotic activities on human lymphoblastoid TK6 cells. METHODS:We attempt to characterize the apoptotic pathway activated by DGA. Apoptosis was detected by DNA fragmentation, PARP cleavage and ...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Bhouri W,Boubaker J,Skandrani I,Ghedira K,Chekir Ghedira L

    更新日期:2012-06-11 00:00:00

  • MicroRNA-96-3p promotes metastasis of papillary thyroid cancer through targeting SDHB.

    abstract:Background:MicroRNA (MiRNA) is a small non-coding RNA which is implicated in a cohort of biological function in cancer, including proliferation, metastasis, apoptosis and invasion. MiR-96 has been reported to be involved in many cancers, including papillary thyroid cancer. However, the role of miR-96-3p in papillary th...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Zhao X,Li Y,Zhou Y

    更新日期:2019-11-12 00:00:00

  • SMAD6, positively regulated by the DNM3OS-miR-134-5p axis, confers promoting effects to cell proliferation, migration and EMT process in retinoblastoma.

    abstract:Background:Retinoblastoma (RB) is acknowledged to be the commonest intraocular malignancy in infants and children and the outcome of RB patients is unfavorable due to limited early diagnosis and effective therapy. SMAD family member 6 (SMAD6) has been reported in the initiation and progression of human cancers by actin...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Wang H,Ji X

    更新日期:2020-01-22 00:00:00

  • NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression.

    abstract:Background:Melanoma is an extremely aggressive malignant skin tumor with high mortality. Many types of long noncoding RNAs and microRNAs have been reported to be associated with the oncogenesis of melanoma. However, a novel lncRNA-NEAT has not been thoroughly investigated in melanoma cancer. The purposes of this study ...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Ding F,Lai J,Gao Y,Wang G,Shang J,Zhang D,Zheng S

    更新日期:2019-08-22 00:00:00

  • Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells.

    abstract:BACKGROUND:Apigenin (4',5,7-trihydroxyflavone) was recently shown effective in inhibiting several cancers. The aim of this study was to investigate the effect and mechanism of apigenin in the human bladder cancer cell line T24 for the first time. METHODS:T24 cells were treated with varying concentrations and time of a...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Zhu Y,Mao Y,Chen H,Lin Y,Hu Z,Wu J,Xu X,Xu X,Qin J,Xie L

    更新日期:2013-06-01 00:00:00

  • MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells.

    abstract:BACKGROUND:Pancreatic cancer is currently one of the leading causes of cancer deaths without any effective therapies. Mir-145 has been found to be tumor-suppressive in various types of cancers. The aim of this study is to investigate the role of miR-145 in pancreatic cancer cells and explore its underlying mechanism. ...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Wang H,Hang C,Ou XL,Nie JS,Ding YT,Xue SG,Gao H,Zhu JX

    更新日期:2016-08-25 00:00:00

  • Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells.

    abstract:BACKGROUND:Osteosarcoma (OS) is a malignant tumor of the bone mostly observed in children and adolescents. The current treatment approach includes neoadjuvant and adjuvant chemotherapy; however, drug resistance often hinders therapy in OS patients. Also, the post-relapse survival of OS patients is as low as 20%. We the...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Saini H,Sharma H,Mukherjee S,Chowdhury S,Chowdhury R

    更新日期:2021-01-14 00:00:00

  • Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis.

    abstract:Background:Some studies have investigated the prognostic value exhibited by the Prognostic Nutritional Index (PNI) in patients suffering diffuse large B-cell lymphoma (DLBCL), but varying results were obtained. In order to determine the specific prognostic value more accurately, a meta-analysis was conducted in this st...

    journal_title:Cancer cell international

    pub_type: 杂志文章,评审


    authors: Luan C,Wang F,Wei N,Chen B

    更新日期:2020-09-15 00:00:00

  • The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells.

    abstract:Background:New drugs for adrenocortical carcinoma (ACC) are needed because most patients undergo rapid disease progression despite surgery and adjuvant therapy with mitotane. In this study, we aimed to investigate the in vitro effects of different chemotherapy drugs, alone or combined with mitotane, on the viability of...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Silveira E,Cavalcante IP,Kremer JL,de Mendonça POR,Lotfi CFP

    更新日期:2018-03-01 00:00:00

  • microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer.

    abstract:BACKGROUND:Non-small cell lung cancer (NSCLC) is the largest histological subgroup of lung cancer and has increased in prevalence in China over the past 5 years. The 5-year survival rate has remained at 15-20 %, with a median survival of 8-12 months. The tumorigenesis and progression of NSCLC is orchestrated by numerou...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Chen S,Li P,Yang R,Cheng R,Zhang F,Wang Y,Chen X,Sun Q,Zang W,Du Y,Zhao G,Zhang G

    更新日期:2015-09-17 00:00:00

  • Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma.

    abstract:BACKGROUND:G protein-coupled receptor family C group 5 member A (GPRC5A), a retinoic acid-inducible gene, is a lung tumor suppressor. Previously, we showed that repression of GPRC5A expression was associated with pathologic differentiation grade of oral squamous cell carcinomas (OSCC) and overexpression of GPRC5A gene ...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Liu S,Ye D,Wang T,Guo W,Song H,Liao Y,Xu D,Zhu H,Zhang Z,Deng J

    更新日期:2017-03-02 00:00:00

  • Autophagy regulation using luteolin: new insight into its anti-tumor activity.

    abstract::Application of novel methods in cancer therapy is important in terms of management and treatment of the life-threatening disorder. It appears that autophagy is a potential target in cancer therapy, as a variety of drugs targeting autophagy have shown great potential in reducing the viability and proliferation of cance...

    journal_title:Cancer cell international

    pub_type: 杂志文章,评审


    authors: Ashrafizadeh M,Ahmadi Z,Farkhondeh T,Samarghandian S

    更新日期:2020-11-04 00:00:00

  • Understanding the colon cancer stem cells and perspectives on treatment.

    abstract::An area of research that has been recently gaining attention is the relationship between cancer stem cell (CSC) biology and chemo-resistance in colon cancer patients. It is well recognized that tumor initiation, growth, invasion and metastasis are promoted by CSCs. An important reason for the widespread interest in th...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Garza-Treviño EN,Said-Fernández SL,Martínez-Rodríguez HG

    更新日期:2015-01-28 00:00:00

  • Reshaping the role of m6A modification in cancer transcriptome: a review.

    abstract::N6-methyl-adenosine(m6A) modification emerges as an abundant and dynamic regulation throughout the Eukaryotic transcriptome. Dysregulation of the m6A regulators has increasingly been found in many neoplasms. It is reasonable to believe that m6A changes the fate of cancer cells and subsequently affected all aspects of ...

    journal_title:Cancer cell international

    pub_type: 杂志文章,评审


    authors: Yang G,Sun Z,Zhang N

    更新日期:2020-07-29 00:00:00

  • MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1.

    abstract:Background:Hepatocellular carcinoma (HCC) is one of the most common malignancies with a high morbidity and mortality worldwide. MicroRNAs are key regulators of HCC genesis. However, the regulatory role and underlying mechanisms of microRNA in HCC is still limited. Methods:Cyclin B1 (CCNB1) mRNA levels were examined in...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Gu J,Liu X,Li J,He Y

    更新日期:2019-01-14 00:00:00

  • Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells.

    abstract:BACKGROUND:Alterations in the processing of the genetic information in carcinogenesis result from stable genetic mutations or epigenetic modifications. It is becoming clear that nucleosomal histones are central to proper gene expression and that aberrant DNA methylation of genes and histone methylation plays important ...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Watanabe H,Soejima K,Yasuda H,Kawada I,Nakachi I,Yoda S,Naoki K,Ishizaka A

    更新日期:2008-11-03 00:00:00

  • Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.

    abstract:Background:Alternative splicing (AS) is a key factor in protein-coding gene diversity, and is associated with the development and progression of malignant tumours. However, the role of AS in cervical cancer is unclear. Methods:The AS data for cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) were...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Ouyang D,Yang P,Cai J,Sun S,Wang Z

    更新日期:2020-06-08 00:00:00

  • Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells.

    abstract:Background:Glioma is the most common highly aggressive, primary adult brain tumour. Clinical data show that therapeutic approaches cannot reach the expectations in patients, thus gliomas are mainly incurable diseases. Tumour cells can adapt rapidly to alterations during therapeutic treatments related to their metabolic...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Petővári G,Hujber Z,Krencz I,Dankó T,Nagy N,Tóth F,Raffay R,Mészáros K,Rajnai H,Vetlényi E,Takács-Vellai K,Jeney A,Sebestyén A

    更新日期:2018-12-19 00:00:00

  • Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma.

    abstract:Background:Cholangiocarcinoma (CCA) is an invasive malignancy arising from biliary epithelial cells; it is the most common primary tumour of the bile tract and has a poor prognosis. The aim of this study was to screen prognostic biomarkers for CCA by integrated multiomics analysis. Methods:The GSE32225 dataset was der...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Da Z,Gao L,Su G,Yao J,Fu W,Zhang J,Zhang X,Pei Z,Yue P,Bai B,Lin Y,Meng W,Li X

    更新日期:2020-04-22 00:00:00

  • LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis.

    abstract:Background:Melanoma is the most aggressive type of skin cancer with high mortality rate and poor prognosis. lncRNA MEG3, a tumor suppressor, is closely related to the development of various cancers. However, the role of lncRNA MEG3 in melanoma has seldom been studied. Methods:RT-PCR was used to examine the expressions...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Wu L,Zhu L,Li Y,Zheng Z,Lin X,Yang C

    更新日期:2020-01-10 00:00:00

  • Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer.

    abstract:Background:Kinesin superfamily (KIFs) has a long-reported significant influence on the initiation, development, and progress of breast cancer. However, the prognostic value of whole family members was poorly done. Our study intends to demonstrate the value of kinesin superfamily members as prognostic biomarkers as well...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Li TF,Zeng HJ,Shan Z,Ye RY,Cheang TY,Zhang YJ,Lu SH,Zhang Q,Shao N,Lin Y

    更新日期:2020-04-15 00:00:00

  • Correction to: Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis.

    abstract::[This corrects the article DOI: 10.1186/s12935-020-01426-1.]. ...

    journal_title:Cancer cell international

    pub_type: 已发布勘误


    authors: Li T,Liu Q,Zhang R,Liao Q,Zhao Y

    更新日期:2020-08-18 00:00:00

  • miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1.

    abstract:Background:miR-429 and TLN1 have been shown to affect the biological behaviours of many carcinomas. However, their effects in nasopharyngeal carcinoma (NPC) are not yet clear. Here, we investigated their regulatory relationships and effects on NPC cells. Methods:TargetScan was used to predict the regulatory relationsh...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Wang Z,Zhu Z,Lin Z,Luo Y,Liang Z,Zhang C,Chen J,Peng P

    更新日期:2019-04-30 00:00:00

  • The role of A20 in the pathogenesis of lymphocytic malignancy.

    abstract:: Autoimmune phenomena were identified in many different cases of hematological diseases and solid tumors, which may be due to alterations in the expression and function of the NF-κB signaling pathway. Recently, a number of studies have shown that the deletion or mutation of A20, a negative regulator of NF-κB, is frequ...

    journal_title:Cancer cell international

    pub_type: 杂志文章


    authors: Zhang F,Yang L,Li Y

    更新日期:2012-11-07 00:00:00

  • Correction to: ZEB1‑AS1 initiates a miRNA‑mediated ceRNA network to facilitate gastric cancer progression.

    abstract::[This corrects the article DOI: 10.1186/s12935-019-0742-0.]. ...

    journal_title:Cancer cell international

    pub_type: 杂志文章,已发布勘误


    authors: Ma MH,An JX,Zhang C,Liu J,Liang Y,Zhang CD,Zhang Z,Dai DQ

    更新日期:2019-04-11 00:00:00